Month: October 2021
EU-OSHA throws spotlight on chronic MSDs to mark World Arthritis Day
12/10/2021 EU-OSHA throws spotlight on chronic MSDs to mark World Arthritis Day Image To mark the 2021 edition of the World Arthritis Day (WAD), observed […]
EU-OSHA throws spotlight on chronic MSDs to mark World Arthritis Day
12/10/2021 EU-OSHA throws spotlight on chronic MSDs to mark World Arthritis Day Image To mark the 2021 edition of the World Arthritis Day (WAD), observed […]
EU-OSHA throws spotlight on chronic MSDs to mark World Arthritis Day
12/10/2021 EU-OSHA throws spotlight on chronic MSDs to mark World Arthritis Day Image To mark the 2021 edition of the World Arthritis Day (WAD), observed […]
EU-OSHA throws spotlight on chronic MSDs to mark World Arthritis Day
12/10/2021 EU-OSHA throws spotlight on chronic MSDs to mark World Arthritis Day Image To mark the 2021 edition of the World Arthritis Day (WAD), observed […]
EU-OSHA throws spotlight on chronic MSDs to mark World Arthritis Day
12/10/2021 EU-OSHA throws spotlight on chronic MSDs to mark World Arthritis Day Image To mark the 2021 edition of the World Arthritis Day (WAD), observed […]
EU-OSHA throws spotlight on chronic MSDs to mark World Arthritis Day
12/10/2021 EU-OSHA throws spotlight on chronic MSDs to mark World Arthritis Day Image To mark the 2021 edition of the World Arthritis Day (WAD), observed […]
EU-OSHA throws spotlight on chronic MSDs to mark World Arthritis Day
12/10/2021 EU-OSHA throws spotlight on chronic MSDs to mark World Arthritis Day Image To mark the 2021 edition of the World Arthritis Day (WAD), observed […]
EU-OSHA throws spotlight on chronic MSDs to mark World Arthritis Day
12/10/2021 EU-OSHA throws spotlight on chronic MSDs to mark World Arthritis Day Image To mark the 2021 edition of the World Arthritis Day (WAD), observed […]
EU-OSHA throws spotlight on chronic MSDs to mark World Arthritis Day
12/10/2021 EU-OSHA throws spotlight on chronic MSDs to mark World Arthritis Day Image To mark the 2021 edition of the World Arthritis Day (WAD), observed […]
EU-OSHA throws spotlight on chronic MSDs to mark World Arthritis Day
12/10/2021 EU-OSHA throws spotlight on chronic MSDs to mark World Arthritis Day Image To mark the 2021 edition of the World Arthritis Day (WAD), observed […]
The Vaccine Brawl – A Legal Battle in Process
By MIKE MAGEE The power to mandate vaccines was litigated and resolved over a century ago. Justice John Marshall Harlin, a favorite of current Chief […]
Universal Paid Family and Medical Leave Under Consideration in Congress
The House of Representatives is considering a provision of the Build Back Better Act that would create a universal paid family and medical leave program. […]
Blood marker could help ID those at risk of debilitating peripheral artery disease
Researchers have shown that high levels of a specific protein circulating in the blood accurately detect a severe type of peripheral artery disease that narrows […]
Merck Acquires Acceleron for $11.5 Billion
Merck’s 11.5 billion acquisition of Acceleron gives them access to their lead therapeutic candidate, sotatercept.
PharmaShots Weekly Snapshots (September 27 – October 01, 2021)
BMS Reports EMA’s Validation of MAA for Relatlimab and Nivolumab as 1L Treatment for Unresectable or Metastatic Melanoma Published: Oct 1, 2021 | Tags: BMS, […]
Fierce Pharma Asia—Biogen-Eisai’s Alzheimer’s drug filing; Samsung-Roche deal growth; Sunovion-Otsuka neuro pact
Fierce Pharma Asia—Biogen-Eisai’s Alzheimer’s drug filing; Samsung-Roche deal growth; Sunovion-Otsuka neuro pact aliu Fri, 10/01/2021 – 09:16
Novartis and MMV Report Positive Results for Next-Generation Antimalarial Therapy
Novartis and Medicines for Malaria Venture have reported positive results from the Phase IIb study, evaluating a new non-artemisinin combination to treat uncomplicated malaria in […]
Myasthenia Gravis Treatment Market: How the Leading Companies are Countering the Rising Prevalence?
Myasthenia Gravis is an autoimmune disease that causes muscle weakness and fatigue. It occurs when the communication between nerve cells and muscles is disrupted. This […]
Australian Health Protection Principal Committee (AHPPC) statement on COVID-19, schools and reopening Australia
A statement from the Australian Health Protection Principal Committee (AHPPC) on COVID-19, schools and reopening Australia.
Three-Year Data Demonstrates Further Evidence for Dovato as a Switch Option for HIV
ViiV Healthcare has presented three-year clinical trial, reinforcing that the two-drug regimen Dovato can be used as a viable switch option for people living with […]
CHMP Performs Accelerated Assessment of Booster Dose of Spikevax
EMA’s CHMP is going to perform an accelerated assessment of data submitted by Moderna regarding the use of a booster dose of Spikevax.
4D Pharma presence growing in microbiome field
The interim results from Aberdeen-born 4D Pharma revealed that the first half of 2021 was a “significant period” for the biotechnology firm, according Proactive.
UK headquartered N4 Pharma granted European patent for cancer treatment and vaccine delivery system
The European Patent Office (EPO) has granted a patent to specialist pharmaceutical company, N4 Pharma, for its Nuvec cancer treatment and vaccine delivery system.
Australian Health Protection Principal Committee (AHPPC) statement on visitation in residential aged care facilities
A statement from the Australian Health Protection Principal Committee (AHPPC) on National Principles for Infection Prevention and Control in Quarantine.
Australian Health Protection Principal Committee (AHPPC) statement on mandatory vaccination of all workers in health care settings
A statement from the Australian Health Protection Principal Committee (AHPPC) on National Principles for Infection Prevention and Control in Quarantine.
Merck says experimental pill cuts worst effects of COVID-19
If cleared, the drug would be the first pill shown to treat COVID-19, a potentially major advance in efforts to fight the pandemic. All COVID-19 […]
Australian Health Protection Principal Committee (AHPPC) statement on the role of ventilation in reducing the risk of transmission of COVID-19
A statement from the Australian Health Protection Principal Committee (AHPPC) on the role of ventilation in reducing the risk of transmission of COVID-19
The future is digital – reimagining patient engagement
Interactive patient systems provide a path forward, bringing much-needed efficiency to day-to-day operations for our caregivers, and providing patients and families with the comfort and […]
EMA’s Innovation Task Force Will Provide Support for Developers to Minimize Animal Testing
EMA is providing support via its Innovation Task Force (ITF) for developers to help them reduce, replace, and refine animal use in drug development.
Pruning the dendritic tree
Researchers have shed light on the function of the enzyme SLK for the development of nerve cells in the brain. If it is missing, the […]
Merck says antiviral pill effective against COVID-19, lifting hopes for first oral drug
The drugmaker, along with partner Ridgeback Biotherapeutics, plan to ask the FDA for emergency authorization “as soon as possible.”
BMS Reports EMA’s Validation of MAA for Relatlimab and Nivolumab as 1L Treatment for Unresectable or Metastatic Melanoma
Shots: The MAA was based on the efficacy & safety results from the P-II/III RELATIVITY-047 trial that evaluates the fixed-dose combination of relatlimab (160mg) + […]
COVID-19 Deaths Among Older Adults During the Delta Surge Were Higher in States with Lower Vaccination Rates
This analysis looks at the relationship between vaccination rates and COVID-19 deaths for adults 65 and older since the Delta variant took hold, and finds […]
StartUPDATES: New developments for healthcare startups
Check out the latest news from HealthMine, Vital, Cleerly Health and more.
Booster Dose of the Pfizer/BioNTech COVID-19 Vaccine (Comirnaty)
Date: October 18, 2021 Issue #: 1635 Summary: On September 22, on the advice of its Vaccines and Related Biologic Products Advisory Committee, the FDA […]
Merck and Ridgeback Report Interim Results of Molnupiravir in P-III MOVe-OUT Trial for the Treatment of COVID-19
Shots: The P-III MOVe-OUT trial evaluates molnupiravir vs PBO in 1550 non-hospitalized adult patients with COVID-19 with at least one risk factor associated with poor […]
Merck says COVID-19 pill cuts death risk in half, will seek emergency authorization
Pharmaceutical company Merck on Friday said it will seek an emergency authorization for their oral antiviral COVID-19 treatment after the medicine was shown to reduce […]
Accelerated Approval of Aducanumab: Where Do We Stand Now?
Annals of Pharmacotherapy, Volume 56, Issue 6, Page 736-739, June 2022. Aducanumab was approved by the Food and Drug Administration (FDA) in June 2021 to […]
Accelerated Approval of Aducanumab: Where Do We Stand Now?
Annals of Pharmacotherapy, Ahead of Print. Aducanumab was approved by the Food and Drug Administration (FDA) in June 2021 to treat Alzheimer disease (AD). Its […]
Accelerated Approval of Aducanumab: Where Do We Stand Now?
Annals of Pharmacotherapy, Ahead of Print. Aducanumab was approved by the Food and Drug Administration (FDA) in June 2021 to treat Alzheimer disease (AD). Its […]
Accelerated Approval of Aducanumab: Where Do We Stand Now?
Annals of Pharmacotherapy, Ahead of Print. Aducanumab was approved by the Food and Drug Administration (FDA) in June 2021 to treat Alzheimer disease (AD). Its […]
Accelerated Approval of Aducanumab: Where Do We Stand Now?
Annals of Pharmacotherapy, Ahead of Print. Aducanumab was approved by the Food and Drug Administration (FDA) in June 2021 to treat Alzheimer disease (AD). Its […]
Accelerated Approval of Aducanumab: Where Do We Stand Now?
Annals of Pharmacotherapy, Ahead of Print. Aducanumab was approved by the Food and Drug Administration (FDA) in June 2021 to treat Alzheimer disease (AD). Its […]
Accelerated Approval of Aducanumab: Where Do We Stand Now?
Annals of Pharmacotherapy, Ahead of Print. Aducanumab was approved by the Food and Drug Administration (FDA) in June 2021 to treat Alzheimer disease (AD). Its […]
Accelerated Approval of Aducanumab: Where Do We Stand Now?
Annals of Pharmacotherapy, Ahead of Print. Aducanumab was approved by the Food and Drug Administration (FDA) in June 2021 to treat Alzheimer disease (AD). Its […]
Accelerated Approval of Aducanumab: Where Do We Stand Now?
Annals of Pharmacotherapy, Ahead of Print. Aducanumab was approved by the Food and Drug Administration (FDA) in June 2021 to treat Alzheimer disease (AD). Its […]
Eptacog Beta for Bleeding Treatment and Prevention in Congenital Hemophilia A and B With Inhibitors: A Review of Clinical Data and Implications for Clinical Practice
Annals of Pharmacotherapy, Volume 56, Issue 7, Page 831-838, July 2022. Objective:To review the pharmacology, dosing and administration, safety, clinical efficacy, and role of eptacog […]
Eptacog Beta for Bleeding Treatment and Prevention in Congenital Hemophilia A and B With Inhibitors: A Review of Clinical Data and Implications for Clinical Practice
Annals of Pharmacotherapy, Ahead of Print. Objective:To review the pharmacology, dosing and administration, safety, clinical efficacy, and role of eptacog beta in the treatment of […]
Eptacog Beta for Bleeding Treatment and Prevention in Congenital Hemophilia A and B With Inhibitors: A Review of Clinical Data and Implications for Clinical Practice
Annals of Pharmacotherapy, Ahead of Print. Objective:To review the pharmacology, dosing and administration, safety, clinical efficacy, and role of eptacog beta in the treatment of […]
Eptacog Beta for Bleeding Treatment and Prevention in Congenital Hemophilia A and B With Inhibitors: A Review of Clinical Data and Implications for Clinical Practice
Annals of Pharmacotherapy, Ahead of Print. Objective:To review the pharmacology, dosing and administration, safety, clinical efficacy, and role of eptacog beta in the treatment of […]
Eptacog Beta for Bleeding Treatment and Prevention in Congenital Hemophilia A and B With Inhibitors: A Review of Clinical Data and Implications for Clinical Practice
Annals of Pharmacotherapy, Ahead of Print. Objective:To review the pharmacology, dosing and administration, safety, clinical efficacy, and role of eptacog beta in the treatment of […]
Eptacog Beta for Bleeding Treatment and Prevention in Congenital Hemophilia A and B With Inhibitors: A Review of Clinical Data and Implications for Clinical Practice
Annals of Pharmacotherapy, Ahead of Print. Objective:To review the pharmacology, dosing and administration, safety, clinical efficacy, and role of eptacog beta in the treatment of […]
Eptacog Beta for Bleeding Treatment and Prevention in Congenital Hemophilia A and B With Inhibitors: A Review of Clinical Data and Implications for Clinical Practice
Annals of Pharmacotherapy, Ahead of Print. Objective:To review the pharmacology, dosing and administration, safety, clinical efficacy, and role of eptacog beta in the treatment of […]
Eptacog Beta for Bleeding Treatment and Prevention in Congenital Hemophilia A and B With Inhibitors: A Review of Clinical Data and Implications for Clinical Practice
Annals of Pharmacotherapy, Ahead of Print. Objective:To review the pharmacology, dosing and administration, safety, clinical efficacy, and role of eptacog beta in the treatment of […]
Eptacog Beta for Bleeding Treatment and Prevention in Congenital Hemophilia A and B With Inhibitors: A Review of Clinical Data and Implications for Clinical Practice
Annals of Pharmacotherapy, Ahead of Print. Objective:To review the pharmacology, dosing and administration, safety, clinical efficacy, and role of eptacog beta in the treatment of […]
Eptacog Beta for Bleeding Treatment and Prevention in Congenital Hemophilia A and B With Inhibitors: A Review of Clinical Data and Implications for Clinical Practice
Annals of Pharmacotherapy, Ahead of Print. Objective:To review the pharmacology, dosing and administration, safety, clinical efficacy, and role of eptacog beta in the treatment of […]
Risk of Gastrointestinal Bleeding on Treatment With Statin Alone or With Concomitant Administration of Warfarin: A Systematic Review and Meta-analysis of 5.3 Million Participants
Annals of Pharmacotherapy, Volume 56, Issue 7, Page 820-830, July 2022. Objective:This study aimed to comprehensively evaluate the risk of gastrointestinal bleeding (GIB) with statin […]
Risk of Gastrointestinal Bleeding on Treatment With Statin Alone or With Concomitant Administration of Warfarin: A Systematic Review and Meta-analysis of 5.3 Million Participants
Annals of Pharmacotherapy, Ahead of Print. Objective:This study aimed to comprehensively evaluate the risk of gastrointestinal bleeding (GIB) with statin monotherapy or with concomitant warfarin […]
Risk of Gastrointestinal Bleeding on Treatment With Statin Alone or With Concomitant Administration of Warfarin: A Systematic Review and Meta-analysis of 5.3 Million Participants
Annals of Pharmacotherapy, Ahead of Print. Objective:This study aimed to comprehensively evaluate the risk of gastrointestinal bleeding (GIB) with statin monotherapy or with concomitant warfarin […]
Risk of Gastrointestinal Bleeding on Treatment With Statin Alone or With Concomitant Administration of Warfarin: A Systematic Review and Meta-analysis of 5.3 Million Participants
Annals of Pharmacotherapy, Ahead of Print. Objective:This study aimed to comprehensively evaluate the risk of gastrointestinal bleeding (GIB) with statin monotherapy or with concomitant warfarin […]
Risk of Gastrointestinal Bleeding on Treatment With Statin Alone or With Concomitant Administration of Warfarin: A Systematic Review and Meta-analysis of 5.3 Million Participants
Annals of Pharmacotherapy, Ahead of Print. Objective:This study aimed to comprehensively evaluate the risk of gastrointestinal bleeding (GIB) with statin monotherapy or with concomitant warfarin […]
Risk of Gastrointestinal Bleeding on Treatment With Statin Alone or With Concomitant Administration of Warfarin: A Systematic Review and Meta-analysis of 5.3 Million Participants
Annals of Pharmacotherapy, Ahead of Print. Objective:This study aimed to comprehensively evaluate the risk of gastrointestinal bleeding (GIB) with statin monotherapy or with concomitant warfarin […]
Risk of Gastrointestinal Bleeding on Treatment With Statin Alone or With Concomitant Administration of Warfarin: A Systematic Review and Meta-analysis of 5.3 Million Participants
Annals of Pharmacotherapy, Ahead of Print. Objective:This study aimed to comprehensively evaluate the risk of gastrointestinal bleeding (GIB) with statin monotherapy or with concomitant warfarin […]
Risk of Gastrointestinal Bleeding on Treatment With Statin Alone or With Concomitant Administration of Warfarin: A Systematic Review and Meta-analysis of 5.3 Million Participants
Annals of Pharmacotherapy, Ahead of Print. Objective:This study aimed to comprehensively evaluate the risk of gastrointestinal bleeding (GIB) with statin monotherapy or with concomitant warfarin […]
Risk of Gastrointestinal Bleeding on Treatment With Statin Alone or With Concomitant Administration of Warfarin: A Systematic Review and Meta-analysis of 5.3 Million Participants
Annals of Pharmacotherapy, Ahead of Print. Objective:This study aimed to comprehensively evaluate the risk of gastrointestinal bleeding (GIB) with statin monotherapy or with concomitant warfarin […]
Risk of Gastrointestinal Bleeding on Treatment With Statin Alone or With Concomitant Administration of Warfarin: A Systematic Review and Meta-analysis of 5.3 Million Participants
Annals of Pharmacotherapy, Ahead of Print. Objective:This study aimed to comprehensively evaluate the risk of gastrointestinal bleeding (GIB) with statin monotherapy or with concomitant warfarin […]
Deep Dive: Communications and Commercialisation
The COVID-19 pandemic kickstarted a period of profound change in how the pharmaceutical industry approaches both communications and commercialisation. In some cases it was an […]
Merck to seek emergency approval for experimental pill that cuts worst effects of coronavirus
If cleared, Merck’s drug – molnupiravir – would be the first pill shown to treat COVID-19, a potentially major advance in efforts to fight the […]
Digital surgery firm Activ raises $45m for AR software
Activ Surgical has raised $45 million in second-round financing to help develop its augmented reality (AR) based software, designed to provide additional information to surgeons […]
BMA polls GPs over withdrawing work or quitting NHS amid mounting abuse
The BMA has launched a poll asking GPs whether they are prepared to quit the NHS, reduce working hours or take other action as the […]
Sanofi Presents Results of Amlitelimab (KY1005) in P-IIa Study for the Treatment of Moderate-To-Severe Atopic Dermatitis at EADV 2021
Shots: The P-IIa study evaluates amlitelimab (IV, low/high dose, q4w over 12wks.) vs PBO in 88 patients with mod. to sev. AD inadequately controlled with […]
Oxford Nanopore makes stellar debut on UK stock market
Shares in DNA sequencing specialist Oxford Nanopore rocketed after the company made its debut on the London Stock Exchange yesterday, rising nearly 50% to propel […]
Merck Says It Has First Effective Antiviral Pill for Covid
The drug maker will seek authorization for molnupiravir, the first drug of its kind for Covid. Experts said such pills could be a powerful tool […]
A Colorado Town Is About as Vaccinated as It Can Get. Covid Still Isn’t Over There.
San Juan County, Colorado, can boast that 99.9% of its eligible population has received at least one dose of covid-19 vaccine, putting it in the […]
Key drug in Sanofi’s $1.45bn Kymab buyout shows promise in eczema
Already a major player in atopic dermatitis with Dupixent, Sanofi looked to expand its position in the category earlier this year when it bought Kymab […]
Why switch to automated CRF annotations?
What is an annotated CRF? An annotated CRF documents the location in a database of the data collected for each question on a form. In […]
Readers and Tweeters Feel Americans’ Pain
Letters to the Editor is a periodic feature. We welcome all comments and will publish a selection. We edit for length and clarity and require full names. This […]
Hospitals Confront Climate Change as Patients Sick From Floods and Fires Crowd ERs
When triple-digit temperatures hit the Pacific Northwest this summer, the emergency room at Seattle’s Harborview Medical Center was ill prepared. Doctors raced to treat heat-aggravated […]
Dermavant Presented Long-Term Results of Tapinarof in P-III PSOARING 3 Study for the Treatment of Plaque Psoriasis at EADV
Shots: The P-III PSOARING 3 LTE study evaluates tapinarof (1%, qd) vs vehicle-controlled cream in 763 patients with PsO for ~40wks. & a 4wks. safety […]
Hotspot for the purposes of Commonwealth support declared for Moorabool Shire, Victoria
The Australian Government Chief Medical Officer, Professor Paul Kelly, has today declared a hotspot for the Victorian local governement area (LGA) of Moorabool Shire for […]
GSK bails on $4.2bn partnership with Merck on cancer drug
GlaxoSmithKline has ended its collaboration with Germany’s Merck KGaA’s cancer treatment bintrafusp alfa, after a trio of failed clinical trials. Given the disappointments the decision […]
Novartis Presented Results of Remibrutinib (LOU064) in P-IIb Study for the Treatment of Chronic Spontaneous Urticaria at EADV
Shots: The P-IIb study evaluates the efficacy & safety of remibrutinib vs PBO in 311 patients with CSU inadequately controlled by H1-antihistamines for 12wks. The […]
4 Ways Hospitals Benefit From Improved Surgery Scheduling
David Bocanegra, R.N., Nurse Informaticist, Intelligent Medical Objects Hospitals rely on elective surgeries as a source of up to 50% of all revenue, allowing them […]
Otsuka Enters into a WW License Agreement with Sunovion and Sumitomo Dainippon to Develop and Commercialize Neuropsychiatric Candidates
Shots: Sunovion to receive $270M up front, $620M as development milestone for 4 candidates & is also eligible to receive sales milestone. Sunovion & Otsuka […]
All approved vaccines now available to everyone 18 years and over
Pfizer, Moderna and AstraZeneca are now available to everyone aged 18 years and over.
Patient testimonial | Kimani Kongo underwent TURBT Surgery in Dubai
Introduction Kimani Kongo, 57, from Kenya, had undergone surgery for TURBT in Kenya but it was not done successfully. He was looking for another TURBT […]
Cipla eyes acquisitions after Covid windfall
Founded in 1935 by Hamied’s grandfather in then-colonial Bombay, Cipla made its name globally by pioneering the sale of cheap, generic HIV drugs across Africa […]
International Reference Pricing: Cross-country comparison
The price of pharmaceuticals are much higher in the U.S. than in other countries. Some policymakers have claimed that international reference pricing could be used […]
Piramal Pharma-Walk-In Drive for Formulation / Analytical Development On 2nd Oct’ 2021
Piramal Pharma-Walk-In Drive for Formulation / Analytical Development On 2nd Oct’ 2021 Job Description Company Profile: Piramal Pharma Solutions is the Contract Development and Manufacturing arm […]
ATAGI update following weekly COVID-19 meeting – 29 September 2021
An update from the Australian Technical Advisory Group on Immunisation (ATAGI) following their weekly meeting on 29 September 2021.
Hotspot for the purposes of Commonwealth support extended for NSW, Jervis Bay and the ACT
The Australian Government Chief Medical Officer, Professor Paul Kelly, has today extended the hotspots for the Australian Capital Territory, New South Wales and the Jervis […]
Framework for international travel and COVID-19 vaccines
To enable fully vaccinated Australians to travel, the Australian Government is finalising new arrangements. Find out more.
Biden administration announces rule on implementing ban on ‘surprise’ medical billing
The Biden administration on Thursday released a rule for how health care providers and insurers should implement legislation prohibiting what are known as surprise medical […]
Early accumulation of tau in the brain predicts memory decline in Alzheimer’s disease
Researchers have compared how well different Alzheimer’s biomarkers predict the progression of the disease and its effect on the memory. They found that early accumulation […]
Top 3 COVID-19 vaccine questions – Booster shots, vaccine trial phases, and close vs casual contacts
Professor Michael Kidd, Deputy Chief Medical Officer, answers the top three questions you’ve been asking on our social accounts.
Former Starbucks Exec, White House Official Engskov to Lead Home Health Care Startup
Kris Engskov — an official in the Bill Clinton White House, a long-time executive with Starbucks and most recently president of senior living provider Aegis […]
Global Calcium Pvt. Ltd- Walk-In Interviews for Freshers & Experienced for R&D -Associate On 5th Oct’ 2021
Global Calcium Pvt. Ltd- Walk-In Interviews for Freshers & Experienced for R&D -Associate On 5th Oct’ 2021 Job Description We are hiring M.Sc Chemistry Candidates […]
Ipca Laboratories -Walk-In Interviews for Quality Assurance Dept. On 3rd October 2021
Ipca Laboratories -Walk-In Interviews for Quality Assurance Dept. On 3rd October 2021 Job Description Department: Quality Assurance Positions: Sr. Officer/ Executive/ Sr. Executive Educational Qualification: B.Sc, M.Sc, B.Pharm, […]
Two Alphabet subsidiaries come together, as Onduo sends Fitbits to some of its users
People who access Onduo through their employer will have access to the wearables and Fitbit’s subscription program. Google closed its acquisition of Fitbit earlier this year, […]
Stay in the know with Marketplace reminders
Connect with the Marketplace today, so you don’t miss out on deadline reminders and useful tips. Open Enrollment for 2022 Marketplace coverage starts November 1, […]